Considering that STATH expression is different in both groups, it is possible that the expression of the gene itself and the protein encoded by it, as well as miRNAs regulating its expression, depends on the clinical stage of the ovarian cancer lesions. The gene discussed is STATH; the disease is ovarian cancer.